Shorla Pharma is hoping its agility and speed to market will help it stand out in the crowded oncology field, with the company seeing potential in “re-innovated” therapies that might relieve the burden on patients, especially in a post-COVID-19 era.
Headquartered in Questum, a Clonmel, Ireland-based acceleration center, Shorla Pharma is led by co-founders Sharon Cunningham and Orlaith Ryan
The series A round, which closed in June 2020, was led by Seroba Life Sciences, a European venture capital firm headquartered in Dublin, Ireland, with additional investment from Irish and